コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 GON-14 also contains a putative THAP DNA-binding domain.
2 uperior hemifield defects, and cluster 3 (10 GON) held deep inferior hemifield defects only or in com
5 GON, 347) of 551 AD patients (non-GON, 334; GON, 217) and 1022 eyes (non-GON, 568; GON, 454) of 611
7 334; GON, 217) and 1022 eyes (non-GON, 568; GON, 454) of 611 ED patients (non-GON, 334; GON, 277) we
16 We suggest that control of organ shape by GON-1 and fibulin in C. elegans may provide a model for
19 gon-2 encodes a predicted cation channel (GON-2) of the TRPM subfamily of TRP proteins and is like
26 an ADAMTS 9 and ADAMTS 20, and of C. elegans GON-1, is required for cell migration during embryogenes
27 uman ADAMTS-4 or ADAMTS-9 can substitute for GON-1 in transgenic worms, suggesting functional conserv
28 visual field abnormalities: early glaucoma (GON and abnormal visual field, mean deviation >-6 decibe
33 stimulation of the greater occipital nerve (GON) were studied before and after dural stimulation.
35 patients with glaucomatous optic neuropathy (GON) and 189 eyes of healthy subjects were clustered wit
36 e presence of glaucomatous optic neuropathy (GON) and 24-2 visual field abnormalities: early glaucoma
37 patients with glaucomatous optic neuropathy (GON) and 289 age-matched participants without GON from t
38 2 years) with glaucomatous optic neuropathy (GON) and 45 eyes of 45 controls (48.0 +/- 12.6 years) wi
39 om those with glaucomatous optic neuropathy (GON) can be optimized by training with clustered data.
40 156 eyes with glaucomatous optic neuropathy (GON) determined by masked review with stereoscopic optic
41 h and without glaucomatous optic neuropathy (GON) followed during the first 13 years of the ADAGES un
42 ith glaucomatous-appearing optic neuropathy (GON) from the Diagnostic Innovations in Glaucoma Study (
43 ded as either glaucomatous optic neuropathy (GON) or normal by two independent masked experts, and di
44 diagnosis of glaucomatous optic neuropathy (GON) or ocular hypertension (OHT) and at least 2 disc st
45 f identifying glaucomatous optic neuropathy (GON) using IOP corrected and uncorrected for corneal bio
46 ven eyes with glaucomatous optic neuropathy (GON), 31 with progressive optic neuropathy (PGON) 53 wit
48 (non-GON, 334; GON, 217) and 1022 eyes (non-GON, 568; GON, 454) of 611 ED patients (non-GON, 334; GO
50 -GON, 581; GON, 347) of 551 AD patients (non-GON, 334; GON, 217) and 1022 eyes (non-GON, 568; GON, 45
53 sensitivity and specificity for detection of GON occurred at 20.9 mm Hg for GAT (59%, 90%) and 18.4 m
55 could be mediated by a direct inhibition of GON-2 by GEM-4, since both proteins are predicted to be
56 DAMTS-20 (1911 amino acids) are orthologs of GON-1, an ADAMTS protease required for gonadal morphogen
57 fVEP or SAP was defined as the percentage of GON eyes that had an abnormality on the functional test.
59 2, 22 had field loss at baseline, 7 had only GON, 3 were OHTs and 12 were from the 39 eyes (31%) with
62 ation >-6 decibels [dB]), glaucoma suspects (GON and normal visual field), and ocular hypertensives (
69 ld or suboccipital muscles innervated by the GON induced an increased excitability of dural responses
72 Supramaximal electrical stimulation of the GON (20 s to 5 min) enhanced afferent dural input in 8/2
76 e propose that GEM-1 acts in parallel to the GON-2 channel to promote cation uptake within the develo
77 When the normal group was compared with the GON group, the FDT pattern SD (PSD) area was larger than
79 cluster and spreading 70.5% of the eyes with GON across the other four clusters, in good agreement wi
81 mportant patterns of field loss in eyes with GON in a manner consistent with years of clinical experi
85 of AD (395 eyes) and ED (419) patients with GON and 276 eyes of AD (106) and ED (170) patients with
86 n visual field series from 200 patients with GON confirmed on two occasions by stereophoto review.
87 The holes in the RNFL seen in patients with GON were probably due to a local loss of RNFL fibers and
89 ON) and 289 age-matched participants without GON from the Diagnostic Innovations in Glaucoma Study (D
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。